ARCHIVES

Garb’s Questions, Answers About Cancer Program

This article is from The Cancer Letter archive.

Vol. 06 No. 49 | December 12, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise

October 14, 1988

Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested

February 11, 1977

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014